Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
11 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/11/2962200/0/en/Fulcrum-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
13 Sep 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/fulcrums-muscle-disorder-drug-fails-late-stage-study-2024-09-12/
13 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/13/2946162/0/en/Fulcrum-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
27 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/27/2936611/0/en/Fulcrum-Therapeutics-to-Participate-in-Upcoming-September-Conferences.html
23 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/23/2935086/0/en/Fulcrum-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
19 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/19/2932001/0/en/Fulcrum-Therapeutics-Strengthens-Leadership-Team-with-the-Appointments-of-Isabel-Kalofonos-as-Chief-Commercial-Officer-and-Heather-Faulds-as-Chief-Regulatory-Affairs-Quality-Assura.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?